US 8088926
Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity
granted A61PA61P3/04
Quick answer
US patent 8088926 (Substituted 2-methyl-2-phenoxy-N-propyl-propionamides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity) held by Jenrin Discovery, LLC expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Jenrin Discovery, LLC
- Grant date
- Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 36
- CPC classes
- A61P, A61P3/04